Browsing: Podcasts

The Oncology Podcast – Delivering Oncology News Differently

The Oncology Journal Club Episode 59: Christmas Special 2021 Welcome to the Christmas Special episode of The OJC. There are no papers this week – instead we’ve a fun Christmas quiz, the best of this year’s bloopers and a surprise musical number by one of our favourite guests. Thank you to all our listeners this year. We hope you’ve had as much fun listening as we have had making this great educational podcast. Wishing you all a happy and safe holiday season and a joyful start to the New Year. Watch out for our Year in Review update coming soon including…

The Oncology Journal Club Episode 58: Immune Checkpoint Blockade Efficacy + Treatment of Older Adults Join Eva Segelov, Craig Underhill and Hans Prenen as they chat through the latest papers. In today’s episode Hans Prenen lives up to the challenge of not covering colorectal cancer! Instead he looks at improved prediction of immune checkpoint blockade efficacy across multiple cancer types. Craig talks us through treatment of older adults with cancer and guidelines to improve trial participation. You’ll also find out why Eva Segelov has been a little naughty this week. We’ve quick bites, ‘The Paper That Changed My practice’ segment…

The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed to defend the body from infections. New research at the University of Arizona Health Sciences, USA, found that patients undergoing active chemotherapy had a lower immune response to two doses of the COVID-19 vaccine, but a third dose increased response. “We wanted to make sure we understand the level of protection the COVID-19 vaccines are offering our cancer patients, especially as restrictions were being eased and more contagious variants were starting to spread,” said…

The Oncology Journal Club Episode 57: Do You Mind if I Record? Join Eva Segelov, Craig Underhill and Hans Prenen as they chat through the latest papers. Today’s papers are thought provoking – Craig ask’s ‘Do you mind if I record?’ Hans is focused on cell-free DNA from bile and Eva talks us through the COVID CAPTURE study. You’ll hear details on updated antiemetics guidelines, patients’ expectations of the benefits from genomic tumour testing and the importance of a warm welcome. In ‘The Paper That Changed My Practice’ segment – we hear from Nicola O’Neil a young medical oncologist from…

The Oncology Journal Club Episode 56: Is food the future of cancer treatment?  Is the future of cancer treatment food? Hans thinks so! This week he presents Nature papers focused on diet. Eva talks us through breast cancer patients with low hormone receptor positivity. And Craig presents the Dutch PLASTIC study provoking a great discussion around PET scans for staging locally advanced gastric cancer. You’ll also find out links between immune checkpoint inhibitors and decreased incidence of second primary cancers. And the Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms.…

The European Cancer Organisation is pleased to announce the launch of the ‘Time To Act’ Data Navigator – a novel interactive visualisation tool presenting data on the impact of COVID-19 on cancer across an initial set of 17 European countries. COVID-19 has dramatically affected cancer control and care delivery across Europe. As identified by our Data Intelligence work, an estimated 100 million screening tests were not performed overall in Europe, as many as one million cancers may have gone undiagnosed, while up to half of all cancer patients were affected by treatment delays. The burden of COVID-19 has also impacted…

The Oncology Journal Club Episode 55: The Gut Microbiota, Electronic Health Records and COVID Risks This week Eva talks us through a paper which will be very helpful for current practice. It looks at risk prediction of COVID-19 related deaths and hospital admissions in adults after vaccination. Hans buried himself in Science and Cell papers this week for his main paper and quick bites. All are focused on the microbiota, the role of bacteria and following an elemental diet. Fascinating stuff! And Craig brings us back down to the ground with a practice changing paper. He looks at oncology patients’…

A new podcast exploring the role of theranostics in neuroendocrine tumours – in celebration of World NET Cancer Day Rachael Babin chats to Simone Leydon and Aviral Singh about the future of theranostics in Australia. In today’s podcast we’re chatting about the recently held Theranostics Roundtable virtual meeting and exploring the future role of theranostics for the management of NETs. Today is World NET Cancer Day – a global initiative to draw attention to under-diagnosed neuroendocrine cancer. As Simone mentions in the podcast, NeuroEndocrine Cancer Australia has today launched a National Action Plan. The plan has been developed in collaboration…

The Oncology Journal Club Episode 54: Cancer Care in the Wake of a Cyber Attack Join Eva Segelov, Craig Underhill and Hans Prenen as they chat through the latest papers in this week’s episode of The OJC. This week Eva talks us through tumour burden and efficacy of immune-checkpoint inhibitor. Hans gets stuck into aligning tumour mutational burden quantification across diagnostic platforms and Craig details the CheckMate 142 Study. You’ll find out how to deliver Cancer Care in the Wake of a Cyberattack and phew, Hans can relax – Eva tells us that coffee is still good for you. We’ve…

How do we solve the problem of apathy in neuro-oncology research? Rachael Babin chats to Lance Kawaguchi about the Cure Brain Cancer Foundation’s Clinical Accelerator. Cure Brain Cancer Foundation recently launched the world’s largest brain-cancer dedicated Clinical Accelerator program – with up to $2million in funding to support brain cancer research and fast-track treatment to patients. This is in addition to an Early Career Research Fellowship the Foundation has recently awarded, worth $345,000. Available across Australia and New Zealand, the clinical accelerator program will support researchers to progress ideas from early-stage, pre-clinical research, into therapeutic products that show proof-of-concept and…

1 2 3 9